Cytosorbents To Implement 1-For-20 Reverse Stock Split, Stock Down In Pre-Market
(RTTNews) - Thursday, Cytosorbents Corporation (CTSO) announced its plan to implement a one-for-twenty reverse stock split of its common stock, par value $0.001 per share, effective September 8, 2026.
The reverse stock split is intended to increase the per-share trading price of the common stock to help the company satisfy Nasdaq's $1.00 minimum bid price requirement for continued listing on The Nasdaq Stock Market LLC.
Notably, this move will not change the company's total number of authorized shares of common stock.
In pre-market hours, CTSO was trading at $0.3398, down 11.46 percent on the Nasdaq.
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.